PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series.
Jeremy D WardMark FowlerAriannette Robledo-GomezShaun M GoodyearAdel KardoshEizaburo SasatomiPublished in: Journal of gastrointestinal oncology (2024)
PB-ASCs are notably enriched in inflammatory response and showed significantly higher PD-L1 expression than PB-AC (P<0.001), suggesting a potential therapeutic role for immune checkpoint inhibitors in managing patients with PB-ASC.